However, it has been reported to be used recreationally at high doses ranging between 80 and 400 mg, which have been described as producing euphoria, amphetamine-like effects, sedation, and hallucinogenic effects, along with anxiety, nausea, diarrhea, and sometimes panic attacks, as well as depressive symptoms once the drug had worn off. At very high doses (e.g., 240 mg, or between 200 and 600 mg), fenfluramine induces a psychedelic state resembling that produced by lysergic acid diethylamide (LSD). Indirect (via induction of serotonin release) and/or direct activation of the 5-HT2A receptor would be expected to be responsible for the psychedelic effects of the drug at sufficient doses. References
Further reading
Gustafsson BI, Tømmerås K, Nordrum I, Loennechen JP, Brunsvik A, Solligård E, Fossmark R, Bakke I, Syversen U, Waldum H (March 2005). "Long-term serotonin administration induces heart valve disease in rats". Circulation. 111 (12): 1517–22. doi:10.1161/01.CIR.0000159356.42064.48. PMID 15781732. Welch, J. T.; Lim, D. S. (2007). "The Synthesis and Biological Activity of Pentafluorosulfanyl Analogs of Fluoxetine, Fenfluramine, and Norfenfluramine". Bioorganic & Medicinal Chemistry. 15 (21): 6659–6666. doi:10.1016/j.bmc.2007.08.012. PMID 17765553. External links
"Fenfluramine". Drug Information Portal. U.S. National Library of Medicine. "Fenfluramine hydrochloride". Drug Information Portal. U.S. National Library of Medicine. Inchem.org - Fenfluramine hydrochloride
Plateau iris is a less common medical condition of the eye resulting from anterior displacement of the peripheral iris by the ciliary body causing angle closure glaucoma. First line treatment for all causes of narrow angle glaucoma is laser iridotomy. If narrow angle glaucoma persists after iridotomy then it is called plateau iris syndrome and subsequently managed either medically (miotics) or surgically (laser peripheral iridoplasty). Plateau iris is a less common form of narrow angle glaucoma and is sometimes discovered after an iridotomy causes a rapid increase in eye pressure. Since this condition is not common, most ophthalmologists are unfamiliar with, and have little experience with, the anatomy of and treatments for this condition. References
Further reading
Wand, M; Grant, WM; Simmons, RJ; Hutchinson, BT (January 1977). "Plateau iris syndrome". Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology. 83 (1): 122–130. PMID 898466. NAID 10029605696. Pavlin, Charles J.; Ritch, Robert; Foster, F. Stuart (April 1992). "Ultrasound Biomicroscopy in Plateau Iris Syndrome". American Journal of Ophthalmology. 113 (4): 390–395. doi:10.1016/s0002-9394(14)76160-4. PMID 1558112. Ritch, Robert (April 1992). "Plateau Iris Is Caused by Abnormally Positioned Ciliary Processes". Journal of Glaucoma. 1 (1): 23–26. doi:10.1097/00061198-199204000-00006. S2CID 72047734. Diniz Filho, Alberto; Cronemberger, Sebastião; Mérula, Rafael Vidal; Calixto, Nassim (October 2008). "Plateau iris". Arquivos Brasileiros de Oftalmologia. 71 (5): 752–758. doi:10.1590/S0004-27492008000500029. PMID 19039479. Ritch, Robert; Tham, Clement C.Y; Lam, Dennis S.C (January 2004). "Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome". Ophthalmology. 111 (1): 104–108. doi:10.1016/j.ophtha.2003.05.001. PMID 14711720.